Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia
GlobeNewswire, Inc.
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, October 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric...
Global Insurance Brokerage Market 2026: Top 20 Brokers Generate $122 bn as Growth Slows
EIN Presswire
NEW YORK, NY, UNITED STATES, November 3, 2026 /EINPresswire.com/ -- The world's 20 largest insurance and reinsurance brokers generated approximately $122 bn in combined revenue in 2025, according to Beinsure and AM Best's latest data.
SEALSQ to Host “Quantum Days” Event in Cannes as Official Sponsor of the First World Quantum Cannes Festival
GlobeNewswire, Inc.
Geneva, Switzerland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- A day of keynotes and expert panels on November 19 at the Hôtel Barrière Le Majestic, following the World Quantum Cannes Festival on November 17 and 18, with speakers from Quobly, EeroQ,...
Swiss Heatwaves Drive Increase in Summer Mortality
MENAFN
(MENAFN) Switzerland recorded around 600 more deaths than normally expected between June and September as the country endured its hottest summer since temperature records began in 1864. Mortality figures released by the Federal Statistical Office...
SOMAÍ Launches Soma OG Medical Cannabis Flower in Switzerland
EIN Presswire
LISBON, PORTUGAL, October 6, 2026 /EINPresswire.com/ -- SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, today announced the launch of Soma OG, its own medical...
Swiss President Warns International Order Faces Growing Pressure
MENAFN
(MENAFN) Swiss President Guy Parmelin warned Tuesday that the international system established after World War II is facing "severe constraints" as conflicts intensify, geopolitical tensions increase and confidence in multilateral institutions...
Kymanox Launches KymaBridge, an Intelligence Platform Connecting Pharma and Biotech Innovators with Drug Delivery Device Technologies
GlobeNewswire, Inc.
Raleigh-Durham, North Carolina; King of Prussia, Pennsylvania, USA; Bern, Switzerland, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kymanox®, a leading global life sciences consulting and professional services firm supporting the development and...
Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy
GlobeNewswire, Inc.
ZUG, Switzerland, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS) a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated...
Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL , Oct. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global disposable medical devices market to grow from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, at a CAGR of 4.9% during the forecast period....
Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension
GlobeNewswire, Inc.
Two oral presentations at AHA Hypertension 2026 will highlight the substantial antihypertensive efficacy of aprocitentan in two hypertension populations from the PRECISION study: patients with obesity and patients across the...
Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
GlobeNewswire, Inc.
BASEL, Switzerland, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Today Ultragenyx announced that the European Medicines Agency (EMA) has validated the Company's Marketing Authorisation Application (MAA) for its investigational gene therapy, rebisufligene...
CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
GlobeNewswire, Inc.
ZUG, Switzerland and BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), today announced that a poster presentation highlighting the Company’s Phase 1 clinical data of its investigational CRISPR/Cas9 gene-edited...
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
GlobeNewswire, Inc.
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have...
Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration
GlobeNewswire, Inc.
MDS-UPDRS motor scores demonstrated stability to baseline recorded at study entry with no disease progression among the 12 evaluable participants who completed 12 months of daily oral administration of rexaceract by August 31, 2026 Participants...
Santhera Pharmaceuticals Half Year Results for the six months ending 30 June 2026
GlobeNewswire, Inc.
Ad hoc announcement pursuant to Art. 53 LR. A conference call will be held on September 30, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release Strong momentum and expanding global access position AGAMREE® for...
Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders
GlobeNewswire, Inc.
BETHESDA, Md., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule...
SEALSQ Highlights Its Subsidiary IC’Alps’ Low-Power, Secure ASIC Design Expertise for Implantable and Connected Medical Devices
GlobeNewswire, Inc.
Geneva, Switzerland, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Featured in the DeviceMed Buyer’s Guide 2026–2027, IC’Alps develops custom integrated circuits for medical technology applications where ultra-low-power operation, compact form factors,...
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
GlobeNewswire, Inc.
SAN DIEGO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have...
Evosep and Mass Dynamics Join Forces to Standardize Proteomics Sample Preparation for Pharma
GlobeNewswire, Inc.
SINGAPORE, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Evosep™, a global leader in standardized proteomics workflows, today announced a strategic collaboration with Mass Dynamics™, the collaborative software environment for modern proteomics teams....
The Anatomical Models Market Is Projected to Reach $62.56 Billion by 2030 Driven by Robust Industry Expansion
EIN Presswire
The Business Research Company’s Anatomical Models Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, October 30, 2026 /EINPresswire.com/ -- The anatomical models market is steadily...
Sign up for:
Switzerland Health Monitor
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.